$CTIC
CTI BioPharma Corp
PRICE
$6.25 -
Delayed Price
VOLUME
1,072,197
DAY RANGE
- 6.26
52 WEEK
1.43 - 6.52
Join Discuss about CTIC with like-minded investors
@soheil.n #StockTraders.NET
$CTIC - nice...will be looking for pops ...covered some already
78 Replies 7 👍 7 🔥
@soheil.n #StockTraders.NET
$CTIC - possible FRD ...looking for a push towards 4.2s to add to existing position $KR - may look to buy dips for an EP play $BBY - if it pushes right off open will look to ss...but if hits 104s will look to get on dips
52 Replies 14 👍 7 🔥
Key Metrics
Market Cap
681.04 M
Beta
0.81
Avg. Volume
6.32 M
Shares Outstanding
108.97 M
Yield
0%
Public Float
0
Next Earnings Date
2022-08-04
Next Dividend Date
Company Information
CTI BioPharma Corp. is a biopharmaceutical company focused on the acquisition, development and commercialization of novel targeted therapies for blood-related cancers that offer a unique benefit to patients and their healthcare providers. The company concentrates its efforts on treatments that target blood-related cancers where there is an unmet medical need. In particular, we are focused on evaluating pacritinib, our sole product candidate currently in active late-stage development, for the treatment of adult patients with myelofibrosis. In addition, the company has recently started developing pacritinib for use in hospitalized patients with severe COVID-19, in response to the COVID-19 pandemic. The company's headquartered in Seattle, Washington.
CEO: Adam Craig
Website: www.ctibiopharma.com
HQ: 3101 Western Ave Ste 800 Seattle, 98121-3017 Washington
Related News